{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:37:46Z","timestamp":1774975066009,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5158,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1994,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>OBJECTIVE <\/jats:bold> The aim of this study to evaluate during normal pregnancy plasma bioavailable testosterone and androstanediol glucuronide levels.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> Bioavailable testosterone, androstanediol glucuronide and SHBG levels were evaluated every 4 weeks from week 6 to week 38 in 10 normal pregnant women. We also measured plasma oestradiol, oestriol, \u0394<jats:sup>4<\/jats:sup>\u2010androstenedione, 17\u2010hydroxyprogesterone, progesterone and testosterone.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> The mean bioavailable testosterone levels were within the range of non\u2010pregnant women but with an increasing trend until delivery. Androstanediol glucuronide had increased at weeks 6 and 8, decreased at week 14, remained low at week 30, and increased again at week 34. SHBG was significantly correlated with testosterone, oestradiol and oestriol. No correlation could be established between androstanediol glucuronide and any other parameter.<\/jats:p><jats:p><jats:bold>DISCUSSION <\/jats:bold> Bioavailable testosterone (non\u2010SHBG bound testosterone) represents the sum of free testosterone plus albumin bound testosterone. The increase in testosterone concentrations with decreased albumin levels during pregnancy, could suggest reduced metabolic clearance of testosterone throughout pregnancy. No correlation was established between the decrease in androstanediol glucuronide and increase in progesterone, suggesting that the decrease in androstanediol glucuronide is not a consequence of the inhibitory effect of progesterone on 5\u03b1\u2010reductase activity.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1994.tb02478.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:59:47Z","timestamp":1205751587000},"page":"263-267","source":"Crossref","is-referenced-by-count":58,"title":["Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy"],"prefix":"10.1111","volume":"40","author":[{"given":"V\u00e9ronique","family":"Kerlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Nahoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Th\u00e9r\u00e8se","family":"Le Martelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Pierre","family":"Bercovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(80)90912-6"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)48738-8"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-5-873"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9378(77)90815-8","article-title":"Testosterone and dihydrotestosterone in maternal and cord blood and in amniotic fluid","volume":"129","author":"Dawood M.Y.","year":"1977","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-1-58"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90243-4"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110558"},{"key":"e_1_2_1_9_1","first-page":"334","article-title":"Etat hormonal de la grossesse: modification du Cortisol et de la testosterone","volume":"48","author":"Laudat M.H.","year":"1987","journal-title":"Annales \u010fEndocrinologie, Paris"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-4-705"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)45254-4"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-1-142"},{"key":"e_1_2_1_13_1","first-page":"928","article-title":"Variations en fonction de \u013e\u00e2ge du glucuronide \u010fandrostanediol plasmatique chez \u013ehomme","volume":"38","author":"Nahoul K.","year":"1990","journal-title":"Pathologic Biologie (Paris)"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(90)90287-3"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(87)90079-3"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/37.5.667"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-28-1-34"},{"key":"e_1_2_1_18_1","first-page":"239","article-title":"Les androg\u00e8nes plasmatiques chez le gar\u00e7on de la naissance \u00e0\u013eadolescence","volume":"26","author":"Roger M.","year":"1979","journal-title":"Annates de Pediatric"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106917"},{"key":"e_1_2_1_20_1","first-page":"161","volume-title":"Comptes Rendus des 3 \u00e8mes Journ\u00e9es nationales de M\u00e9decine Perinatale","author":"Scholler R.","year":"1973"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(74)90099-7"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1981.tb01202.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb01266.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1994.tb02478.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1994.tb02478.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T02:37:43Z","timestamp":1698115063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1994.tb02478.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["10.1111\/j.1365-2265.1994.tb02478.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02478.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}